Bulenox: 91% Off Qualification Option 1 - 25K Eval for $13
Bulenox bumped Qualification Option 1 from 89% to 91% off with code FPF. The 25K intraday trailing eval is $13 and the 50K is $16, until October 13. Option 2 stays 75% off, and Momentum and Fast Track are still 40% off until October 15.
Funded Program Finder may earn a commission if you sign up through links on this page, at no extra cost to you. Affiliate disclosure.

Momentum and Fast Track
The Qualification sale is over, but Momentum and Fast Track are 40% off until October 15.
These deals have ended. Current Bulenox and other prop firm deals are on the discounts page.
Qualification Prices
| Size | Option 1 eval (91% off) | Master activation | Option 1 all-in | Option 2 eval (75% off) |
|---|---|---|---|---|
| 25K | $13 | $143 | $156 | $36$179 all-in |
| 50K | $16 | $148 | $164 | $44$192 all-in |
| 100K | $19 | $248 | $267 | $54$302 all-in |
| 150K | $29 | $498 | $527 | $81$579 all-in |
Qualification is a two-step price: the eval now, the Master activation fee once you pass. If you fail, the eval is all you spent - $13 on a 25K.
Qualification Rules
| Size | Profit target | Max drawdown | DLL (Option 1) | DLL (Option 2) | Contracts |
|---|---|---|---|---|---|
| 25K | $1,500 | $1,500 | None | $500 | 3 |
| 50K | $3,000 | $2,500 | None | $1,100 | 7 |
| 100K | $6,000 | $3,000 | None | $2,200 | 12 |
| 150K | $9,000 | $4,500 | None | $3,300 | 15 |
Option 1 has an intraday trailing drawdown and no daily loss limit. Option 2 has an end-of-day drawdown with a daily loss limit. There is no minimum number of days to pass and no consistency rule in the evaluation.
Still On: Momentum and Fast Track 40% Off
| Size | Momentum | Fast Track |
|---|---|---|
| 25K | $56 | $203 |
| 50K | $86 | $293 |
| 100K | $149 | $389 |
| 150K | $215 | $473 |
Momentum has no activation fee and Fast Track skips the evaluation entirely. Both are 40% off until October 15 - two days after the Qualification deals end.
Which One to Pick?
Cheapest shot: Qualification Option 1 at $13 for a 25K, if you are fine paying the activation when you pass. No activation fee at all: Momentum from $56. No eval: Fast Track from $203. Compare all of them with other firms on the price list.
Bulenox 91% Off FAQ
What is the Bulenox 91% off deal?
Bulenox raised the Qualification Option 1 discount to 91% off with code FPF. Option 1 is the intraday trailing drawdown Qualification account. It runs until October 13, 2026.
How much is a Bulenox Qualification account with 91% off?
Option 1 is $13 for the 25K, $16 for the 50K, $19 for the 100K and $29 for the 150K. You pay the Master activation fee once you pass: $143, $148, $248 and $498, so $156, $164, $267 and $527 all-in.
What is the difference between Bulenox Qualification Option 1 and Option 2?
Option 1 has an intraday trailing drawdown and no daily loss limit, and is 91% off. Option 2 has an end-of-day drawdown with a daily loss limit of $500, $1,100, $2,200 and $3,300, and is 75% off. Both end October 13.
Is Bulenox Momentum or Fast Track on sale too?
Yes. Momentum and Fast Track are 40% off until October 15. Momentum is $56, $86, $149 and $215 with no activation fee, and Fast Track direct funding is $203, $293, $389 and $473.
Do I pay an activation fee on Bulenox Qualification?
Yes. Qualification is a two-step price: the discounted evaluation now, then a Master activation fee when you pass. Momentum and Fast Track have no activation fee.
When do the Bulenox deals end?
Qualification Option 1 (91% off) and Option 2 (75% off) end October 13, 2026. Momentum and Fast Track (40% off) end October 15, 2026.
Bulenox at 91% off - bullish or bearish?
Affiliate disclosure: Funded Program Finder is an independent affiliate site. We may earn a commission when you buy through our links, at no additional cost to you. Rankings and comparisons are based on our own analysis of each firm's published rules. Read the full disclosure.
Risk disclaimer: Trading futures involves substantial risk of loss and is not suitable for everyone. Past performance is not indicative of future results. This article is for information only and is not financial advice. Check the firm's current rules before you buy.